For: | Wu XB, Hou SL, Liu H. Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large B-cell lymphoma patients. World J Clin Cases 2021; 9(32): 9825-9834 [PMID: 34877321 DOI: 10.12998/wjcc.v9.i32.9825] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i32/9825.htm |
Number | Citing Articles |
1 |
Merih REİS ARAS, Hacer Berna AFACAN ÖZTÜRK, Fatma YILMAZ, Ümit Yavuz MALKAN, Ahmet Kürşad GÜNEŞ, Murat ALBAYRAK. Does Systemic Immune Inflammation Index Predicts Survival In Diffuse Large B Cell Lymphoma Patients?. Hitit Medical Journal 2023; 5(3): 170 doi: 10.52827/hititmedj.1301431
|
2 |
Naokazu Nakamura, Hiroko Tsunemine, Tomomi Sakai, Nobuyoshi Arima. Biomarkers for predicting response to corticosteroid therapy for immune thrombocytopenic purpura. British Journal of Haematology 2023; 201(4): 774 doi: 10.1111/bjh.18670
|
3 |
Paolo Tini, Elisa Cinelli, Mariya Yavorska, Flavio Donnini, Francesco Marampon, Pierpaolo Pastina, Giovanni Rubino, Salvatore Chibbaro, Alfonso Cerase, Maria Antonietta Mazzei, Anna Maria Di Giacomo, Giuseppe Minniti. Serum lactate dehydrogenase as a prognostic marker for treatment response in IDH wild-type glioblastoma patients undergoing stupp protocol. Journal of Neuro-Oncology 2024; doi: 10.1007/s11060-024-04862-5
|
4 |
Chengdong Lu, Jianyun Long, Haiyuan Liu, Xupin Xie, Dong Xu, Xin Fang, Yuandong Zhu. Red blood cell distribution width‐to‐albumin ratio is associated with all‐cause mortality in cancer patients. Journal of Clinical Laboratory Analysis 2022; 36(5) doi: 10.1002/jcla.24423
|
5 |
海霞 文. Research Progress on the Application Value of Peripheral Blood Detection Indicators in Prognostic Evaluation of Diffuse Large B-Cell Lymphoma. Advances in Clinical Medicine 2023; 13(06): 10560 doi: 10.12677/ACM.2023.1361477
|
6 |
Yajiao Liu, Li Sheng, Haiying Hua, Jingfen Zhou, Ying Zhao, Bei Wang. A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma. Cancer Management and Research 2023; : 651 doi: 10.2147/CMAR.S408100
|
7 |
Hua Yang, Yang Xun, Chao Ke, Kensuke Tateishi, Hua You. Extranodal lymphoma: pathogenesis, diagnosis and treatment. Molecular Biomedicine 2023; 4(1) doi: 10.1186/s43556-023-00141-3
|
8 |
Amaylia Oehadian, Andini Kartikasari, Lusi Mersiana, Stephanie Gunadi, Gusti Fungani, Putri Vidyaniati, Dimmy Prasetya, Indra Wijaya, Pandji Fianza, Trinugroho Fadjari, Nanny Sutedjo. Clinical and Biomarker Characteristic of Lymphoma Patients in Hasan Sadikin Lymphoma Registry. Journal of Blood Medicine 2024; : 341 doi: 10.2147/JBM.S472791
|
9 |
Shengjie Li, Zuguang Xia, Jiazhen Cao, Jinsen Zhang, Bobin Chen, Tong Chen, Xin Zhang, Wei Zhu, Danhui Li, Wei Hua, Ying Mao. Proposed new prognostic model using the systemic immune-inflammation index for primary central nervous system lymphoma: A prospective-retrospective multicohort analysis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1039862
|
10 |
Yusuf Akın, Mehdi Karasu, Abdulmelik Deniz, Çetin Mirzaoğlu, Hasan Ata Bolayır. Predictive value of the systemic immune inflammatory index in cardiac syndrome x. BMC Cardiovascular Disorders 2023; 23(1) doi: 10.1186/s12872-023-03157-3
|
11 |
Zaijing Fan, Lihong Shou. Prognostic and clinicopathological impacts of systemic immune-inflammation index on patients with diffuse large B-cell lymphoma: a meta-analysis. Therapeutic Advances in Hematology 2023; 14 doi: 10.1177/20406207231208973
|
12 |
Yajiao Liu, Li Sheng, Haiying Hua, Jingfen Zhou, Ying Zhao, Bei Wang. An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231180785
|
13 |
Alejandro García-Núñez, Gema Jiménez-Gómez, Antonio Hidalgo-Molina, Juan Antonio Córdoba-Doña, Antonio León-Jiménez, Antonio Campos-Caro. Inflammatory indices obtained from routine blood tests show an inflammatory state associated with disease progression in engineered stone silicosis patients. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-11926-x
|
14 |
Amirmohammad Rezaei, Mohammad Ebrahim Ghafari, Younes Sohrabi, Fereshteh Aliasghari, Saeed Yousefinejad, Esmaeel Soleimani, Saeed Jafari. Systemic inflammation indices as hematological biomarkers of inflammatory response in non-silicotic workers exposed to respirable silica dust. Toxicology Letters 2024; 395: 26 doi: 10.1016/j.toxlet.2024.03.005
|